Authors

David Mulder

Senior associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Senior associate

Read More

Agnieszka Sztoldman

Senior associate

Read More
Authors

David Mulder

Senior associate

Read More

Christian Dekoninck

Partner

Read More

Adrian Toutoungi

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr. Angela Knierim

Senior associate

Read More

Agnieszka Sztoldman

Senior associate

Read More

23 November 2020

Pharmaceutical patent law – 2 of 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

In this series

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

Quick read

by Multiple authors

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

Quick read

by Multiple authors

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Scientist studying molecule model
Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9 November 2020
Quick read

by multiple authors

Click here to find out more
warsaw
Life sciences & healthcare

CJEU ruling to liberalise parallel import in Poland

25 August 2020
IN-DEPTH ANALYSIS

by Agnieszka Sztoldman

Click here to find out more
pills
Coronavirus

Patent law in emergency situations

14 July 2020
QUICK READ

by David Mulder

Click here to find out more